| Kamel H, Iadecola C. Brain-immune interactions and ischemic stroke:clinical implications[J]. Arch Neurol,2012, 69:576-581. Iade cola C, An r at he r J. The immu nolog y of stroke:from mechanisms to translation[J]. Nat Med,2011, 17:796-808. Yilmaz G, Granger DN. Leukocyte recruitment and ischemic brain injury[J]. Neuromolecular Med, 2010,12:193-204. Hyman MC, Petrovic-Djergovic D, Visovatti SH, et al. Self-regulation of inflammatory cell trafficking in mice by the leukocyte surface apyrase CD39[J]. J Clin Invest, 2009, 119:1136-1149. Swit zer JA, Hess DC, Erg ul A, et al. Mat r ix metalloproteinase-9 in an exploratory t r ial of intravenous minocycline for acute ischemic stroke[J].Stroke, 2011, 42:2633-2635. Cardona AE, Pioro EP, Sasse ME, et al. Control of microglial neurotoxicity by the fractalkine receptor[J].Nat Neurosci, 2006, 9:917-924. Magnus T, Wiendl H, Kleinschnitz C. Immune mechanisms of stroke[J]. Curr Opin Neurol, 2012,25:334-340. Burnstock G. Purinergic signalling and disorders of the central nervous system[J]. Nat Rev Drug Discov, 2008, 7:575-590. Peachell P. Reg ulat ion of mast cells by bet aagonists[J]. Clin Rev Allergy Immunol, 2006, 31:131- 142. Kono H, Rock KL. How dying cells alert the immune system to danger[J]. Nat Rev Immunol, 2008, 8:279-289. Felger JC, Abe T, Kaunzner UW, et al. Brain dendritic cells in ischemic stroke:time course, activation state,and origin[J]. Brain Behav Immun, 2010, 24:724-737. Br a it VH, Ja ckma n KA, Wa lduck AK, e t a l.Mechanisms contributing to cerebral infarct size after stroke:gender, reperfusion, T lymphocytes, and Nox2-derived superoxide[J]. J Cereb Blood Flow Metab,2010, 30:1306-1317. Gelderblom M, Leypoldt F, Steinbach K, et al.Temporal and spatial dynamics of cerebral immune cell accumulation in stroke[J]. Stroke, 2009, 40:1849-1857. Shichita T, Sugiyama Y, Ooboshi H, et al. Pivotal role of cerebral interleukin-17-producing gamma delta T cells in the delayed phase of ischemic brain injury[J].Nat Med, 2009, 15:946-950. Re n X, Ak iyosh i K, Va nde nba rk AA, e t a l . CD4+FoxP3+ regulatory T-cells in cerebral ischemic stroke[J]. Metab Brain Dis, 2011, 26:87-90. Becker KJ. Sensitization and tolerization to brain antigens in stroke[J]. Neuroscience, 2009, 158:1090-1097. Becker K, Kindrick D, McCarron R, et al. Adoptive transfer of myelin basic protein-tolerized splenocytes to naive animals reduces infarct size:a role for lymphocytes in ischemic brain injury?[J]. Stroke,2003, 34:1809-1815. Su b r ama n i a n S, Zh a ng B, Ko s a k a Y, e t a l .Re c ombi n a n t T c e l l r e c e p t o r l ig a n d t r e a t s experimental stroke[J]. Stroke, 2009, 40:2539-2545. Vogelgesang A, May VE, Gr u nwald U, et al.Functional status of peripheral blood T-cells in ischemic stroke patients[J]. PLoS One, 2010, 5:e8718. Chamorro A, Urra X, Planas AM. Infection after acute ischemic stroke:a manifestation of braininduced immunodepression[J]. Stroke, 2007, 38:1097-1103. Prass K, Meisel C, Hoflich C, et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation[J]. J Exp Med, 2003, 198:725-736. Gendron A, Teitelbaum J, Cossette C, et al. Temporal effects of left versus right middle cerebral artery occlusion on spleen lymphocyte subsets and mitogenic response in Wistar rats[J]. Brain Res, 2002, 955:85-97. Jickling GC, Xu H, Stamova B, et al. Signatures of cardioembolic and large-vessel ischemic stroke[J].Ann Neurol, 2010, 68:681-692. Nathan C, Ding A. Nonresolving inflammation[J].Cell, 2010, 140:871-882. Davalos D, Grutzendler J, Yang G, et al. ATP mediates rapid microglial response to local brain injury in vivo [J]. Nat Neurosci, 2005, 8:752-758. Napoli I, Neumann H. Microglial clearance function in health and disease[J ]. Neuroscience, 2009,158:1030-1038. Spite M, Serhan CN. Novel lipid mediators promote resolution of acute inflammation:impact of aspirin and statins[J]. Circ Res, 2010, 107:1170-1184. Gesuete R, Storini C, Fantin A, et al. Recombinant C1 inhibitor in brain ischemic injury[J]. Ann Neurol,2009, 66:332-342. Furuya K, Takeda H, Azhar S, et al. Examination of several potential mechanisms for the negative outcome in a clinical stroke trial of enlimomab, a murine anti-human intercellular adhesion molecule-1antibody:a bedside-to-bench study[J]. Stroke, 2001,32:2665-2674. Kunz A, Pa rk L, Abe T, et al. Neurovascula r protection by ischemic tolerance:role of nitric oxide and reactive oxygen species[J]. J Neurosci, 2007,27:7083-7093. Frenkel D, Huang Z, Maron R, et al. Nasal vaccination with myelin oligodendrocyte glycoprotein reduces stroke size by inducing IL-10-producing CD4+ Tcells[J]. J Immunol, 2003, 171:6549-6555. Liesz A, Suri-Payer E, Veltkamp C, et al. Regulatory Tcells are key cerebroprotective immunomodulators in acute experimental stroke[J]. Nat Med, 2009, 15:192-199. Ge n a i n CP, Ab e l K, Be lma r N, e t a l . La t e complications of immune deviation therapy in a nonhuman primate[J]. Science, 1996, 274:2054-2057. Gee JM, Zierath D, Hadwin J, et al. Long term immunologic consequences of experimental stroke and mucosal tolerance[J]. Exp Transl Stroke Med,2009, 1:3. |
